Literature DB >> 6407500

A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers.

W H Wilson, H Higano, Y Papadatos, S Kelwala, T A Ban.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6407500      PMCID： PMC1427650          DOI： 10.1111/j.1365-2125.1983.tb02129.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  Antidepressants and the muscarinic acetylcholine receptor.

Authors:  S H Snyder; H I Yamamura
Journal:  Arch Gen Psychiatry       Date:  1977-02

2.  Salivary secretion in depressive illness.

Authors:  B M DAVIES; J B GURLAND
Journal:  J Psychosom Res       Date:  1961-10       Impact factor: 3.006

Review 3.  Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics.

Authors:  B Blackwell
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

4.  Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  V Claassen; J E Davies; G Hertting; P Placheta
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

5.  Possible lack of anticholinergic effects with mianserin: a pilot study.

Authors:  W H Wilson; W M Petrie; T A Ban
Journal:  J Clin Psychiatry       Date:  1980-02       Impact factor: 4.384

6.  Tricyclic side effects without tricyclics in depression.

Authors:  R J Mathew; M Weinman; J L Claghorn
Journal:  Psychopharmacol Bull       Date:  1980-07

7.  A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects.

Authors:  A W Peck; C E Bye; M Clubley; T Henson; C Riddington
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

8.  Xerostomia and sialorrhea in depression.

Authors:  R J Mathew; M Weinman; J L Claghorn
Journal:  Am J Psychiatry       Date:  1979-11       Impact factor: 18.112

9.  Anticholinergic activity of two tricyclic antidepressants.

Authors:  B Blackwell; A Stefopoulos; P Enders; R Kuzma; A Adolphe
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

10.  Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness.

Authors:  K Ghose; A Coppen; P Turner
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530
View more
  12 in total

Review 1.  Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; A Ward
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 2.  Fluvoxamine: an antidepressant for the elderly?

Authors:  J M Kellett
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

Review 3.  Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

4.  Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone.

Authors:  M Gallerani; L Grassi; F Ferrari; G Calò; R Manfredini
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 5.  Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

Authors:  Susan M Cheer; David P Figgitt
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation.

Authors:  H V Curran; P Shine; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.

Authors:  H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 8.  Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Authors:  G J H Dumont; S J de Visser; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 9.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

10.  Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial.

Authors:  T Bougerol; C Uchida; J P Gachoud; M Köhler; H Mikkelsen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.